BDSX
Biodesix Inc
29.10$
-4.2%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 23.9% | 23.0% | 21.4% | 21.6% | 23.0% | 21.3% | 20.6% | 20.1% | 18.9% | 17.0% | 16.5% | 17.9% | 17.5% | |
| 76.1% | 77.0% | 78.6% | 78.4% | 77.0% | 78.7% | 79.4% | 79.9% | 81.1% | 83.0% | 83.5% | 82.1% | 82.5% | |
| 14.4% | 12.9% | 13.8% | 14.3% | 14.0% | 11.8% | 16.0% | 16.3% | 13.7% | 10.0% | 12.9% | 11.7% | 11.9% | |
| 114.9% | 240.3% | 138.7% | 109.7% | 110.3% | 99.0% | 113.9% | 112.0% | 99.8% | 79.9% | 94.9% | 90.4% | 90.6% | |
| 129.2% | 123.7% | 152.9% | 124.3% | 124.3% | 111.3% | 129.8% | 128.3% | 113.5% | 89.9% | 107.8% | 102.1% | 102.5% | |
| -53.2% | -46.7% | -74.4% | -46.0% | -47.3% | -32.5% | -50.5% | -48.4% | -32.4% | -6.8% | -24.2% | -20.1% | -20.0% | |
| 17.7% | 15.9% | 17.1% | 10.8% | 11.2% | 8.6% | 9.4% | 9.5% | 9.5% | 7.2% | 7.7% | 7.4% | 7.9% | |
| -81.2% | -62.3% | -91.9% | -60.3% | -56.5% | -40.4% | -61.8% | -57.3% | -40.0% | -13.8% | -30.5% | -27.1% | -27.0% | |
| 17.7% | -22.0% | 8.6% | – | -7.8% | -6.3% | – | – | – | – | – | – | – | |
| -81.2% | -62.3% | -91.9% | -60.3% | -56.5% | -40.4% | -61.8% | -57.3% | -40.0% | -13.8% | -30.5% | -27.1% | -27.0% | |
| -54.3% | -37.5% | -65.9% | -42.1% | -37.5% | -25.0% | -44.6% | -40.8% | -24.2% | -1.8% | -17.2% | -15.3% | -13.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.